![](/img/cover-not-exists.png)
616 Pimasertib (MSC1936369B/AS703026), a Selective Oral MEK1/2 Inhibitor, Shows Clinical Activity in Melanoma
Delord, J.P., Houédé, N., Awada, A., Lebbe, C., Lesimple, T., Schellens, J.H.M., Rottey, S., Kefford, R., Rejeb, N., Raymond, E.Volume:
48
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(12)72413-9
Date:
November, 2012
File:
PDF, 60 KB
english, 2012